U. Bekoz Et Al. , "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience," ANNALS OF HEMATOLOGY , vol.99, no.11, pp.2565-2576, 2020
Bekoz, U. Et Al. 2020. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. ANNALS OF HEMATOLOGY , vol.99, no.11 , 2565-2576.
Bekoz, U., Ozbalak, M., Karadurmus, N., Paydaş, S., Turker, A., Toptaş, T., ... Tuglular, T. F.(2020). Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. ANNALS OF HEMATOLOGY , vol.99, no.11, 2565-2576.
Bekoz, Useyin Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience," ANNALS OF HEMATOLOGY , vol.99, no.11, 2565-2576, 2020
Bekoz, Useyin Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience." ANNALS OF HEMATOLOGY , vol.99, no.11, pp.2565-2576, 2020
Bekoz, U. Et Al. (2020) . "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience." ANNALS OF HEMATOLOGY , vol.99, no.11, pp.2565-2576.
@article{article, author={Useyin Bekoz Et Al. }, title={Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience}, journal={ANNALS OF HEMATOLOGY}, year=2020, pages={2565-2576} }